Guías clínicas 246 Preiss L, Konkle BA, Eyster ME, Goedert JJ. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 2006; 107: 892-7. 207.- Franchini M, Capra F, Tagliaferri A, Rossetti G, De Gironcoli M, Rocca P, et al. Update on chronic hepatitis C in hemophiliacs. Haematologica 2002; 87: 542-9. 208.- Lee CA, Sabin CA. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1997; 96: 875-6. 209.- Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996; 94: 746-52. 210.- Dieterich DT. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. Am J Med 1999; 107: 79S-84S. 211.- Assy N, Pettigrew N, Lee SS, Chaudhary RK, Johnston J, Minuk GY. Are chronic hepatitis C viral infections more benign in patients with hemophilia? Am J Gastroenterol 2007; 102: 1672-6. 212.- Wong VS, Baglin T, Beacham E, Wight DD, Petrik J, Alexander GJ. The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol 1997; 97: 343-7. 213.- Telfer P. Liver biopsy for haemophilic patients with chronic HCV infection. Br J Haematol 1997; 99: 239-40. 214.- Venkataramani A, Behling C, Rond R, Glass C, Lyche K. Liver biopsies in adult hemophiliacs with hepatitis C: a United States center’s experience. Am J Gastroenterol 2000; 95: 2374-6. 215.- Mancuso ME, Rumi MG, Santagostino E, Linari S, Coppola A, Mannucci PM, Colombo M. High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Haematologica 2006; 91: 1367-71. 216.- Franchini M, Mengoli C, Veneri D, Mazzi R, Lippi G, Cruciani M. Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin: a meta-analysis. J Antimicrob Chemother 2008; 61: 1191-200. 217.- Patel H, Heathcote EJ. When to treat and the benefits of treating hepatitis C in Guía AUGE MINSAL Virus Hepatitis C - A. Soza R. et al. patients with haemophilia. Haemophilia 2009; 15: 20-32. 218.- Singh G, Sass R, Alamiry R, Zein N, Alkhouri N. Hepatitis C treatment with triple therapy in a patient with hemophilia A. World J Clin Cases 2013; 1: 106-7. 219.- Bini EJ, Perumalswami PV. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions. Hepatology 2010; 51: 759-66. 220.- Chu CJ, Lee SD. Hepatitis B virus/ hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008; 23: 512- 20. 221.- Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, et al. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J Microbiol Immunol Infect 2009; 42: 122-8. 222.- Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El-Serag HB. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology 2013; 58: 538-45. 223.- Dai CY, Yu ML, Chuang WL, Lin ZY, Chen SC, Hsieh MY, et al. Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 2001; 16: 636-40. 224.- Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003; 39: 1036-41. 225.- Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74: 2442-8. 226.- Brass V, Moradpour D. New insights into hepatitis B and C virus coinfection. J Hepatol 2009; 51: 423-5. 227.- Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 2005; 4: 13. 228.- Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14: 64-7. 229.- Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 27-33. 230.- Siddiqui F, Mutchnick M, Kinzie J, Peleman R, Naylor P, Ehrinpreis M. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reactionconfirmed hepatitis C: implications for vaccination strategy. Am J Gastroenterol 2001; 96: 858-63. 231.- Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-2. 232.- Liu JY, Sheng YJ, Hu HD, Zhong Q, Wang J, Tong SW, et al. The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/ hepatitis B virus coinfection: a metaanalysis. Virol J 2012; 9: 186. 233.- European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167-85. 234.- Yu JW, Sun LJ, Zhao YH, Kang P, Gao J, Li SC. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus. Liver Int 2009; 29: 1485-93. 235.- Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, et al. Peginterferon alfa- 2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 2009; 136: 496-504 e493. 236.- Coppola N, Marrone A, Pisaturo M, Starace M, Signoriello G, Gentile I, et al. Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection. Eur J Clin Microbiol Infect Dis 2014; 33: 559-67. Gastroenterol. latinoam 2015; Vol 26, Nº 4: 214-247
gastrolat2015n400006
To see the actual publication please follow the link above